Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7648-7656

  Miller, Jennifer T ^a   Ge, Zheng ^a   Morris, Shannon ^a   Das, Kingshuk ^a   Leis, Jonathan ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANTICODON; ARTICLE; BASE PAIRING; BINDING SITE; GENE DISRUPTION; MOLONEY MURINE SARCOMA ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RNA TRANSLATION; ROUS SARCOMA ONCOVIRUS; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0030796303     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7648-7656.1997     Document Type: Article

References (51)

1. Trp primer is required for efficient initiation of reverse transcription. J. Virol. 66:2464-2472.
2. Aiyar, A., Z. Ge, and J. Leis. 1994. A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J. Virol. 68:611-618.
3. Aiyar, A., Y. Xiang, and J. Leis. 1995. Site-directed mutagenesis using overlap extension PCR. Methods Mol. Biol. 57:177-191.
4. Aiyar, A., P. Hindmarsh, A. M. Skalka, and J. Leis. 1996. Concerted integration of linear retroviral DNA by the ASV integrase in vitro: dependence on both long terminal repeat termini. J. Virol. 70:3571-3580.
5. Aronoff, R., A. M. Hajjar, and M. Linial. 1993. Avian retroviral RNA encapsidation: reexamination of functional 5′ RNA sequences and the role of nucleocapsid Cys-His motifs. J. Virol. 67:178-188.
6. Arts, E., M. Ghosh, P. Jacques, B. Ehresmann, and S. LeGrice. 1996. Restoration of tRNA-primed minus strand DNA synthesis to a reverse transcriptase mutant with tRNA/DNA chimeras: tRNA-viral RNA duplexes and initiation of HIV replication. J. Biol. Chem. 271:9054-9061.
7. Lys-3 interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc. Natl. Acad. Sci. USA 93:10063-10068.
8. Baudin, F., R. Marquet, C. Isel, J.-L. Darlix, B. Ehresmann, and C. Ehresmann. 1993. Functional sites in the 5' region of HIV-1 RNA form defined structural domains. J. Mol. Biol. 229:382-397.
9. Berkhout, B., and I. Schoneveld. 1993. Secondary structure of HIV-2 leader RNA comprising the tRNA-primer binding site. Nucleic Acids Res. 21:1171-1178.
10. Clavel, F., and J. Orenstein. 1990. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J. Virol. 64:5230-5234.
11. Clever, J., C. Saddetti, and T. Parslow. 1995. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 69:2101-2109.
12. Cobrinik, D., A. Aiyar, Z. Ge, M. Katzman, H. Huang, and J, Leis. 1991. Overlapping retroviral U5 sequence elements are required for efficient integration and initiation of reverse transcription. J. Virol. 65:3864-3872.
13. Cobrinik, D., L. Soskey, and J. Leis. 1988. A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J. Virol. 62:3622-3630.
14. Trp as primer for RNA-directed DNA polymerase: structural determinants of function. J. Biol. Chem. 254:1866-1874.
15. Donze, O., and P.-F. Spahr. 1992. Role of the open reading frames of Rous sarcoma virus leader RNA in translation and genome packaging. EMBO J. 11:3747-3757.
16. Donze, O., P. Damay, and P.-F. Spahr. 1995. The first and third uORFs in RSV leader RNA are efficiently translated: implications for translational regulation and viral RNA packaging. Nucleic Acids Res. 23:861-868.
17. Hackett, P. B., M. W. Dalton, D. P. Johnson, and R. B. Petersen. 1991. Phylogenetic and physical analysis of the 5′ leader RNA sequences of avian retroviruses. Nucleic Acids Res. 19:6929-6934.
18. Harrison, G., and A. Lever. 1992. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure, J. Virol. 66:4144-4153.
19. Hayashi, T., T. Shioda, Y. Iwakura, and H. Shibuta. 1992. RNA packaging signal of human immunodeficiency virus type 1. Virology 188:590-599.
20. Lys,3 template/primer. J. Mol. Biol. 247:236-250.
21. Lys,3. EMBO J. 15:917-924.
22. Kang, S.-M., J. Wakefield, and C. Morrow. 1996. Mutations in both the U5 region and primer binding site influence the selection of the tRNA used for initiation of HIV-1 reverse transcription. Virology 222:401-414.
23. Met. J. Virol. 71:207-217.
24. Katz, R., R. Terry, and A. M. Skalka. 1986. A conserved c/s-acting sequence in the 5′ leader of avian sarcoma virus RNA is required for packaging. J. Virol. 59:163-167.
25. Katzman, M., R. A. Katz, A. M. Skalka, and J. Leis. 1989. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63:5319-5327.
26. Knight, J. B., Z. H. Si, and C. M. Stoltzfus. 1994. A base-paired structure in the avian sarcoma virus 5′ leader is required for efficient encapsidation of RNA. J. Virol. 68:4493-4502.
27. Gln,2 as primer in an in vitro primer-utilization assay. Proc. Natl. Acad. Sci. USA 89:9652-9656.
28. Leis, J. 1976. RNA-dependent DNA polymerase activity of RNA tumor viruses. J. Virol. 19:932-939.
29. Lets, J., A. Aiyar, and D. Cobrinik. 1993. Regulation of initiation of reverse transcription of retroviruses, p. 33-47. In A. M. Skalka and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Lever, A., H. Gottlinger, W. Haseltine, and J. Sodroski. 1989. Identification of a sequence for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:4085-4087.
31. Li, X., J. Mak, E. J. Arts, Z. Gu, L. Kldman, M, A. Wainberg, and M. A. Parniak. 1994. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J. ViroL 68:6198-6206.
32. Mann, R., and D. Baltimore. 1985. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J. Virol. 54:401-407.
33. Mansky, L. M., A. E. Krueger, and H, M. Temin. 1995. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′ end of the gag gene. J. Virol. 69:3282-3289.
34. McBride, S., and A. Panganiban. 1996. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:2963-2973.
35. Milligan, J., D. Groebe, G. Witherell, and O, Uhlenbeck. 1987. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15:8783-8798.
36. 35a.Morris, S., and J. Leis. Unpublished data.
37. Mougel, M., Y. Zhang, and E. Barklis. 1996. cis-active structural motifs in specific encapsidation of Moloney murine leukemia virus RNA. J. Virol. 70:5043-5050.
38. Mougel, M., N. Touneki, J.-L. Darlix, J. Paoletti, B. Ehresmann, and C. Ehresmann. 1993. Conformational analysis of the 5′ leader and the gag initiation site of Mo-MuLV RNA and allosteric transitions induced by dimerization. Nucleic Acids Res. 21:4677-4684.
39. Moustakas, A., T. Sonstegaard, and P. Hackett. 1993. Alterations of the three short open reading frames in the Rous sarcoma virus leader RNA modulate viral replication and gene expression. J. Virol. 67:4337-4349.
40. Murphy, J. E., and S. P. Goff. 1989. Construction and analysis of deletion, mutations in the U5 region of Moloney murine leukemia virus: effects 41 RNA packaging and reverse transcription. J. Virol. 63:319-327.
41. Parkin, N. T., E. A. Cohen, A. Darveau, C. Rosen, W. Haseltine, and N. Sonenberg. 1988. Mutational analysis of the 5′ non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. EMBO J. 7:2831-2837.
42. Rizvi, T., and A. Panganiban. 1993. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type I particles. J. Virol. 67:2681-2688.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
44. Schwartz, D. E., R. Tizard, and W. Gilbert. 1983. Nucleotide sequence of Rous sarcoma virus. Cell 22:853-869.
45. Tavis, J. E., and D. Ganem. 1995. RNA sequences controlling the initiation and transfer of duck hepatitis B virus minus-strand DNA. J, ViroL 69:4283-4291.
46. Tuerk, C., S. MacDougaK and L. Gold. 1992. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 89:6988-6992.
47. Wakefield, J. K., and C. D. Morrow. 1996. Mutations within the primer binding site of human immunodeficiency virus type 1 define sequence requirements essential for reverse transcription. Virology 220:290-298.
48. His. J. Virol. 70:966-975.
49. Yang, S., and H. Temin. 1994. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13:713-726.
50. Zhang, Y., and E. Barklis. 1995. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69:5716-5722.
51. His. Virology 226:306-317.